L Pedersen

No ORCID on file · 1 paper in corpus

nonrandomized-trial 1985

Endocrine treatment with anti-estrogen, anti-androgen or progestagen of advanced malignant melanoma: three consecutive phase II trials

European journal of cancer & clinical oncology ·doi:10.1016/0277-5379(85)90010-0

Malignant melanoma is generally considered as a hormone-independent tumour. However, epidemiological, clinical and experimental data suggest that steroid hormones can influence the growth of this tumour. The therapeutic efficacy of endocrin…